These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23441660)

  • 1. Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients.
    Nwaba A; MacQuillan G; Adams LA; Garas G; Delriviere L; Augustson B; DeBoer B; Moody H; Jeffrey GP
    Intern Med J; 2013 Mar; 43(3):328-33. PubMed ID: 23441660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation.
    Czubkowski P; Pawłowska J; Jankowska I; Teisseyre M; Kamińska D; Markiewicz M; Ryżko J
    Pediatr Transplant; 2012 Sep; 16(6):E261-4. PubMed ID: 22066835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
    Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J
    Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.
    Paramesh AS; Grosskreutz C; Florman SS; Gondolesi GE; Sharma S; Kaufman SS; Fishbein TM
    Transplantation; 2004 Jan; 77(1):129-31. PubMed ID: 14724447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy.
    Nishi H; Hanafusa N; Kondo Y; Nangaku M; Sugawara Y; Makuuchi M; Noiri E; Fujita T
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):811-9. PubMed ID: 17699291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange therapy for thrombotic thrombocytopenic purpura in pediatric patients with liver transplantation.
    Lee CH; Chen CL; Lin CC; Yang CH; Cheng YF; Wang MC; Eng HL; Liu PP; Chuang FR
    Transplant Proc; 2008 Oct; 40(8):2554-6. PubMed ID: 18929799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-lymphoid cancer after liver transplantation.
    Frezza EE; Fung JJ; van Thiel DH
    Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation.
    Kishida N; Shinoda M; Itano O; Obara H; Kitago M; Hibi T; Yagi H; Abe Y; Matsubara K; Odaira M; Tanabe M; Shimazu M; Kitagawa Y
    Ann Transplant; 2016 Dec; 21():755-764. PubMed ID: 27956735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy in transplantation and malignancy.
    Qu L; Kiss JE
    Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
    Dhakal P; Giri S; Pathak R; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):175-180. PubMed ID: 26259912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.
    Gonwa TA; Mai ML; Melton LB; Hays SR; Goldstein RM; Levy MF; Klintmalm GB
    Transplantation; 2001 Dec; 72(12):1934-9. PubMed ID: 11773892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient.
    Boyer NL; Niven A; Edelman J
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy associated with tacrolimus in lung transplantation.
    Reig Mezquida JP; Jover AS; Ansótegui Barrera E; Escrivá Peiró J; Pastor Colom MD; Pastor Guillem J
    Arch Bronconeumol; 2015 May; 51(5):e23-4. PubMed ID: 25138798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy following intestinal transplantation: a single center experience.
    Dierickx D; Monbaliu D; De Rycke A; Wisanto E; Lerut E; Devos T; Meers S; Darius T; Ferdinande P; Pirenne J
    Transplant Proc; 2010; 42(1):79-81. PubMed ID: 20172285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
    Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
    Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressant-related hip pain after orthotopic liver transplant.
    Li H; He JW; Fu BS; Wang K; Jiang N; Wang GY; Zhang J; Wang GS; Yang Y; Chen GH
    Exp Clin Transplant; 2013 Feb; 11(1):32-8. PubMed ID: 22813534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.
    Epperla N; Hemauer K; Hamadani M; Friedman KD; Kreuziger LB
    Transfusion; 2017 Nov; 57(11):2775-2781. PubMed ID: 28836275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
    Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.